These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19758896)

  • 1. Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.
    Serruys PW; Ong AT; Morice MC; De Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Dawkins K; O'Malley AJ; Bressers M; Donohoe D
    EuroIntervention; 2005 Aug; 1(2):147-56. PubMed ID: 19758896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
    Serruys PW; Daemen J; Morice MC; De Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Dawkins KD; Vranckx P; Bressers M; van Domburg R; Schuijer M; Wittebols K; Pieters M; Stoll HP
    EuroIntervention; 2008 Jan; 3(4):450-9. PubMed ID: 19736087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I.
    Macaya C; García-García HM; Colombo A; Morice MC; Legrand V; Kuck KH; Sheiban I; Suttorp MJ; Carrie D; Vrolix M; Wittebols K; Stoll HP; Donohoe D; Bressers M; Serruys PW
    EuroIntervention; 2006 May; 2(1):69-76. PubMed ID: 19755239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II).
    Kukreja N; Serruys PW; De Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Goedhart D; Macours N; Stoll HP;
    Heart; 2009 Jul; 95(13):1061-6. PubMed ID: 19304671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II).
    Legrand VM; Garg S; Serruys PW; Virtanen KS; Szurawitzki G; Voudris V; Fontanelli A; Endersen K; Kranjec I; Rademaker T; Stefanidis CI; Wittebols K
    EuroIntervention; 2011 Feb; 6(7):838-45. PubMed ID: 21252018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
    van Domburg RT; Daemen J; Morice MC; de Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; van Es GA; Wittebols K; Macours N; Stoll HP; Serruys PW
    EuroIntervention; 2010 Apr; 5(8):962-7. PubMed ID: 20542782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II.
    Vaina S; Voudris V; Morice MC; De Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Schuijer M; Macours N; Stoll HP; Cokkinos DV; Stefanadis C; Serruys PW;
    EuroIntervention; 2009 Jan; 4(4):492-501. PubMed ID: 19284072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.
    Serruys PW; Onuma Y; Garg S; Vranckx P; De Bruyne B; Morice MC; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Schuijer M; Rademaker T; Wittebols K; Stoll HP;
    J Am Coll Cardiol; 2010 Mar; 55(11):1093-101. PubMed ID: 20171036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.
    Rodriguez AE; Maree AO; Mieres J; Berrocal D; Grinfeld L; Fernandez-Pereira C; Curotto V; Rodriguez-Granillo A; O'Neill W; Palacios IF
    Eur Heart J; 2007 Sep; 28(17):2118-25. PubMed ID: 17656352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).
    Tsuchida K; Colombo A; Lefèvre T; Oldroyd KG; Guetta V; Guagliumi G; von Scheidt W; Ruzyllo W; Hamm CW; Bressers M; Stoll HP; Wittebols K; Donohoe DJ; Serruys PW
    Eur Heart J; 2007 Feb; 28(4):433-42. PubMed ID: 17267457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial.
    Valgimigli M; Dawkins K; Macaya C; de Bruyne B; Teiger E; Fajadet J; Gert R; De Servi S; Ramondo A; Wittebols K; Stoll HP; Rademaker TA; Serruys PW
    J Am Coll Cardiol; 2007 Jan; 49(4):431-41. PubMed ID: 17258088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of drug eluting stents in single and multivessel disease: results from a single centre experience.
    Mikhail GW; Airoldi F; Tavano D; Chieffo A; Rogacka R; Carlino M; Montorfano M; Sangiorgi G; Corvaja N; Michev I; Orlic D; Di Mario C; Colombo A
    Heart; 2004 Sep; 90(9):990-4. PubMed ID: 15310680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
    Ix JH; Mercado N; Shlipak MG; Lemos PA; Boersma E; Lindeboom W; O'Neill WW; Wijns W; Serruys PW
    Am Heart J; 2005 Mar; 149(3):512-9. PubMed ID: 15864241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.
    Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R;
    Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II).
    Khattab AA; Daemen J; Richardt G; Rioux P; Amann FW; Levy R; Horvath IG; Teles RC; Ordoubadi F; Pieters M; Wittebols K; Stoll HP; Serruys PW
    Am J Cardiol; 2008 Jun; 101(11):1550-9. PubMed ID: 18489932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.
    Serruys PW; Ong AT; van Herwerden LA; Sousa JE; Jatene A; Bonnier JJ; Schönberger JP; Buller N; Bonser R; Disco C; Backx B; Hugenholtz PG; Firth BG; Unger F
    J Am Coll Cardiol; 2005 Aug; 46(4):575-81. PubMed ID: 16098418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.